BioCentury
ARTICLE | Distillery Techniques

Drug platforms; drug delivery

June 27, 2017 11:02 PM UTC

A method for delivering bispecific T cell-engaging antibodies as engineered mRNAs could prolong the serum half-life of the antibodies to treat cancer. mRNA encoding bispecific antibodies targeting CD3...

BCIQ Company Profiles

BioNTech SE